ANEB — Anebulo Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- $70.11m
- $63.47m
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -0.175 | -30.3 | -6.83 | -11.7 |
Non-Cash Items | 0.001 | 26.8 | 0.481 | 0.885 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 0.023 | -1.45 | 0.908 | 1.16 |
Change in Accounts Receivable | ||||
Change in Prepaid Expenses | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Cash from Operating Activities | -0.151 | -4.87 | -5.44 | -9.68 |
Financing Cash Flow Items | -0.024 | -0.822 | 0 | -0.317 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 3.18 | 21.8 | 0 | 6.38 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 3.02 | 17 | -5.44 | -3.3 |